News & Events
-
January 1, 2017
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Perrone RD, Mouksassi MS, Romero K, Czerwiec FS, Chapman AB, Gitomer BY, Torres VE, Miskulin DC, Broadbent S, Marier JF. Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 2017 Jan.
-
January 1, 2017
Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study
Liepa AM, Bushnell DM, Atkinson TM, DeBusk K, McCarrier KP, Martin ML, et al. Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study. Journal of Thoracic Oncology. 2017;12(1S):S666.
-
January 1, 2017
Preclinical Biomarker Qualification
Sauer JM, Porter AC, Biomarker Programs, Predictive Safety Testing Consortium. Preclinical Biomarker Qualification. Experimental Biology and Medicine (Maywood, NJ). 2017 Jan 1.
-
December 23, 2016
World Parkinson’s Congress 2016: Summary and Photos
In September, Critical Path for Parkinson’s (CPP) participated in the World Parkinson’s Congress in Portland, Oregon. This is a unique meeting that brings together people living with Parkinson’s disease (PD), their care partners, and leading researchers, to learn of current advances in PD research and therapies. This year was the best turnout to date, with... - December 1, 2016